MARKET

TELO

TELO

Telomir Pharms
NASDAQ
1.340
0.000
0.00%
After Hours: 1.310 -0.03 -2.24% 19:24 04/16 EDT
OPEN
1.350
PREV CLOSE
1.340
HIGH
1.370
LOW
1.300
VOLUME
88.61K
TURNOVER
--
52 WEEK HIGH
3.100
52 WEEK LOW
1.050
MARKET CAP
46.07M
P/E (TTM)
-4.0729
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at TELO last week (0406-0410)?
Weekly Report · 3d ago
Weekly Report: what happened at TELO last week (0330-0403)?
Weekly Report · 04/06 09:15
Telomir Pharmaceuticals Regains Nasdaq Listing Rule Compliance
TipRanks · 03/31 21:30
Telomir Pharmaceuticals submits IND to FDA for Telomir-1 in TNBC
TipRanks · 03/31 12:42
Telomir Pharmaceuticals Submits Investigational New Drug Application To FDA To Treat Advanced And Metastatic Triple-Negative Breast Cancer
Benzinga · 03/31 12:23
TELOMIR PHARMACEUTICALS SUBMITS IND TO FDA FOR TELOMIR-1 (TELOMIR-ZN) IN ADVANCED AND METASTATIC TRIPLE-NEGATIVE BREAST CANCER
Reuters · 03/31 11:07
Weekly Report: what happened at TELO last week (0323-0327)?
Weekly Report · 03/30 09:15
Telomir Shareholders Approve Equity Plan and Bylaw Changes
TipRanks · 03/27 22:24
More
About TELO
Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company. The Company is focused on the development of Telomir-1, a novel small molecule metal ion chelator and regulator designed to lengthen the DNA’s protective telomere caps, which are crucial in the aging process. Telomir 1 is being developed to protect stem cells by elongating and stimulating the telomeres to sustain self-renewal. Telomir-1 helps protect against age-related conditions, including Progeria (a rare genetic disorder that causes rapid aging in children), Wilson’s disease (a genetic disorder leading to toxic copper buildup in the body), and age-related macular degeneration (AMD), as well as Type 2 Diabetes, cancer, and Alzheimer’s disease. It is exploring the potential of Telomir-1 with ongoing research in animals and then in humans. It is focused on developing and commercializing TELOMIR-1, proposed to be dosed orally, with the aim of promoting longevity and enhancing overall quality of life.

Webull offers Telomir Pharmaceuticals Inc stock information, including NASDAQ: TELO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TELO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TELO stock methods without spending real money on the virtual paper trading platform.